Eran Bendavid
Academic Appointments
- Assistant Professor, Medicine - General Medical Disciplines
Key Documents
Contact Information
-
Clinical Offices
Infectious Diseases 300 Pasteur DR Grant S-101D MC 5107 Stanford, CA 94305 Tel Work (650) 723-3474 Fax (650) 498-7474
- Academic Offices
Personal Information Email Tel (650) 723-2363 Tel (650) 723-0984Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Infectious Disease
Professional Education
| Fellowship: | Stanford Hospital & Clinics-Room HC 435, CA USA (2009) |
| Internship: | Hospital of the University of Pennsylvania PA (2004) |
| Residency: | Stanford Hospital & Clinics-Room HC 435, CA USA (2005) |
| MS: | Stanford University, Health Services Research (2009) |
| Medical Education: | Harvard Medical School MA (2001) |
| Board Certification: | General Internal Medicine, American Board of Internal Medicine (2006) |
Internet Links
Scientific Focus
Current Research Interests
My research interests involve understanding the relationship between policies and health outcomes in developing countries. I explore how decisions about foreign assistance for health are made, and how those decisions affect health and health delivery systems in recipient countries. I further explore issues of resource allocation in low and middle-income countries through disease modeling and cost-effectiveness analyses.
Publications
- HIV development assistance and adult mortality in Africa. JAMA. 2012; (19): 2060-7
- The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med. 2012; (8): 541-50
- The US Global Health Initiative: informing policy with evidence. JAMA. 2010; (7): 791-2
- Considerations in assessing the evidence and implications of aid displacement from the health sector. PLoS Med. 2013; (1): e1001364
- Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review. PLoS One. 2013; (3): e59551
- Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? Clin Infect Dis. 2012; (10): 1392-9
Help